Poster groups:

  • Breakout room 1: Viral evolution (Moderator: Jenna Kelly)
  • Breakout room 2: Metagenomics and viromics (Moderator: Alban Ramette)
  • Breakout room 3: Viral inhibition (Moderator: Philippe Lemercier)
  • Breakout room 4: Segmented viruses (Moderator: Manja Marz)
  • Breakout room 5: Tools and methods (Moderator: Franziska Hufsky)
  1. Novel design of Nipah Virus inhibitors employing computational techniques | Paridhi Agarwal | Manipal College of Pharmaceutical Sciences, Manipal, India | Viral inhibition
  2. Multi-strain level interactions between a diverse and persistent phage community and its hosts in the honey bee gut. | German Bonilla-Rosso | Universite de Lausanne, Lausanne, Switzerland | Metagenomics and viromics
  3. Large-scale sequence analysis of M genes from influenza A viruses revealed two distinct genotypes within the Eurasian avian-like swine lineage in Europe | Amélie Chastagner | French Agency for Food, Environmental and Occupational Health & Safety (ANSES), Ploufragan, France | Segmented viruses
  4. Studying viral sequence diversity at any given rank of taxonomy lineage by use of an alignment-independent approach | Li Chuin Chong | Perdana University, Perdana, Malaysia | Viral evolution
  5. Multivalent DNA vaccine against group A human rotavirus: A computational approach | Kunal Dutta | Vidyasagar University, Midnapore, India | Segmented viruses
  6. Molecular evolution of coxsackievirus A9 isolates representing evolutionary time span of six decades | Eero Hietanen | University of Turku, Turku, Finland | Viral evolution
  7. INEXTVIR: Next generation sequencing of the virome of agricultural crops and ecosystems across Europe | Kaoutar Daoud Hiri | Josef Stefan International Postgraduate School, Ljubljana, Slovenia | Metagenomics and viromics
  8. Rational Design and development of novel protease inhibitors for Dengue | Suvarna Kini | Manipal College of Pharmaceutical Sciences, Manipal, India | Viral inhibition
  9. Molecular Differences in Influenza A (H3N2) Surface Proteins Between the 2016-17 and 2017-18 US Influenza Seasons | Nicholas Kovacs | Centers for Disease Control and Prevention, Atlanta, USA | Segmented viruses
  10. RNA modification detection with direct RNA nanopore sequencing | Sebastian Krautwurst | Friedrich Schiller University Jena, Jena, Germany | Tools and methods
  11. Development of novel benzothiazole derivatives as E6 inhibitors against HPV induced cervical cancer | Avinash Kumar | Manipal College of Pharmaceutical Sciences, Udupi, India | Viral inhibition
  12. Evolution of Potato virus Y genome-linked protein (VPg) in the light of its interaction with host translation initiation factor eIF4E | Marina Lebedeva | All-Russia Research Institute of Agricultural Biotechnology, Moscow, Russia | Viral evolution
  13. Intra-host diversity of the mycovirus CHV-1 within natural Cryphonectria parasitica infections and a culture collection | Deborah Leigh | Swiss Federal Institute for Forest, Snow and Landscape Research (WSL), Zurich, Switzerland | Viral evolution
  14. Annotation of SARS-CoV-2 in ViralZone: From proteins to virus life cycle | Philippe Lemercier | Swiss Institute of Bioinformatics, Lausanne, Switzerland | Viral inhibition
  15. Machine learning approach for predicting novel human Cytomegalovirus epitopes | Ihsan Muchsin | University of Würzburg, Würzburg, Germany | Tools and methods
  16. Reassortment and Adaptive Mutations of An Emerging Avian Influenza Virus H7N4 Subtype in China | Bingqian Qu | University Heidelberg, Heidelberg, Germany | Segmented viruses
  17. Exploration of Small Molecule Entry Disruptors for Chikungunya Virus by Targeting Matrix Remodelling Associated (Mxra8) Protein | Ekta Rathi | Manipal College of Pharmaceutical Sciences, Udupi, India | Viral inhibition
  18. V-pipe: A bioinformatics pipeline for viral sequencing data | Ivan Topolsky | ETHZ / SIB, Basel, Switzerland | Tools and methods
  19. CIAlign – A highly customisable command line tool to clean and interpret multiple sequence alignments | Charlotte Tumescheit | University of Cambridge, Cambridge, United Kingdom | Tools and methods
  20. Gut virome in patients with chronic liver disease | Lore Van Espen | KU Leuven, Leuven, Belgium | Metagenomics and viromics